Progress in Understanding Cystic Fibrosis

Dinesh Sriramulu

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/147080

Full metadata record

DC Field	Value	Language
dc.contributor.author	Dinesh Sriramulu
dc.date.accessioned	2022-05-02T08:30:04Z	-
dc.date.available	2022-05-02T08:30:04Z	-
dc.date.issued	2017
dc.identifier.isbn	9789535132912 9789535132929
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/147080	-
dc.language.iso	eng
dc.publisher	IntechOpen
dc.relation.isbasedon	10.5772/63263
dc.relation.uri	https://www.intechopen.com/books/progress-in-understanding-cystic-fibrosis
dc.rights.uri	CC BY-NC-ND (姓名標示-非商業性-禁止改作)
dc.source	DOAB
dc.subject.classification	Genetics
dc.subject.other	Staphylococcus aureus
dc.subject.other	bacteriophage
dc.subject.other	phage therapy
dc.subject.other	vB_SauM-fRuSau02
dc.subject.other	Twortlikevirus
dc.subject.other	antibiotic
dc.subject.other	antimicrobial resistance
dc.subject.other	magistral preparation
dc.subject.other	compounding pharmacy
dc.subject.other	phage therapy
dc.subject.other	regulatory framework
dc.subject.other	personalized medicine
dc.subject.other	bacteriophage
dc.subject.other	phage
dc.subject.other	horizontal gene transfer
dc.subject.other	co-evolution
dc.subject.other	phage therapy
dc.subject.other	industrial phage application
dc.subject.other	antimicrobial resistance (AMR)
dc.subject.other	Germany
dc.subject.other	pH stability
dc.subject.other	phage-host interactions
dc.subject.other	genomics
dc.subject.other	antibiotic-resistance
dc.subject.other	phage preparation
dc.subject.other	lysins
dc.subject.other	biofilms
dc.subject.other	typhoid fever
dc.subject.other	Salmonella Typhi
dc.subject.other	extended-spectrum beta lactamases (ESBL)
dc.subject.other	Democratic Republic of the Congo
dc.subject.other	bacteriophages
dc.subject.other	MALDI-MS
dc.subject.other	Staphylococcus
dc.subject.other	bacteriophages
dc.subject.other	phage therapy
dc.subject.other	Kayvirus
dc.subject.other	Viral proteins
dc.subject.other	bacteriophage
dc.subject.other	therapy
dc.subject.other	phage therapy
dc.subject.other	bacterial disease
dc.subject.other	infection
dc.subject.other	target selection
dc.subject.other	Bacteriophage
dc.subject.other	phage therapy
dc.subject.other	resistance
dc.subject.other	adaptation
dc.subject.other	prophage
dc.subject.other	production
dc.subject.other	regulation
dc.subject.other	phage therapy
dc.subject.other	viral genomes
dc.subject.other	best practices
dc.subject.other	IND
dc.subject.other	high-throughput sequencing
dc.subject.other	bacteriophages
dc.subject.other	phages
dc.subject.other	food safety
dc.subject.other	foodborne illness
dc.subject.other	phage therapy
dc.subject.other	history of science
dc.subject.other	science communication
dc.subject.other	bacteriophage
dc.subject.other	phage therapy
dc.subject.other	sustainable agriculture
dc.subject.other	zoonosis
dc.subject.other	antibiotic resistance
dc.subject.other	phage therapy
dc.subject.other	experimental therapy
dc.subject.other	phage cocktails
dc.subject.other	anti-phage antibodies
dc.subject.other	prophage
dc.subject.other	immunomodulation
dc.subject.other	phage therapy
dc.subject.other	evolution
dc.subject.other	bacterial resistance
dc.subject.other	virulence
dc.subject.other	Listeria ivanovii
dc.subject.other	bacteriophages
dc.subject.other	alginate
dc.subject.other	production
dc.subject.other	disinfection
dc.subject.other	phagodisinfection
dc.subject.other	virus–host interactions
dc.subject.other	bacteriophage efficacy
dc.subject.other	gastrointestinal tract
dc.subject.other	phage therapy
dc.subject.other	bacteriophage
dc.subject.other	phage therapy
dc.subject.other	antimicrobial resistance
dc.subject.other	antibiotic
dc.subject.other	global health
dc.subject.other	developing countries
dc.subject.other	infectious disease
dc.subject.other	bacteriophage
dc.subject.other	phage
dc.subject.other	phage therapy
dc.subject.other	phage-resistance
dc.subject.other	phage therapy
dc.subject.other	bacterial infection
dc.subject.other	capsule depolymerase
dc.subject.other	antibiotic
dc.subject.other	animal model
dc.subject.other	bacterial resistance
dc.subject.other	bacteriophage
dc.subject.other	immunology
dc.subject.other	innate immunity
dc.subject.other	adaptive immunity
dc.subject.other	human host
dc.subject.other	phage-human host interaction
dc.subject.other	bacterial infection
dc.subject.other	antibiotic resistance
dc.subject.other	bacteriophage
dc.subject.other	antibiotic therapy
dc.subject.other	phage therapy
dc.subject.other	cases report
dc.subject.other	abortive infection
dc.subject.other	prophage
dc.subject.other	adsorption
dc.subject.other	Enterococcus
dc.subject.other	rhamnopolysaccharide
dc.subject.other	bacteriophage
dc.subject.other	phage therapy
dc.subject.other	Staphylococcus aureus
dc.subject.other	biofilm
dc.subject.other	antimicrobial
dc.subject.other	frequency of resistance
dc.subject.other	phage sensitivity
dc.subject.other	resistance management
dc.subject.other	nontraditional antibacterial
dc.subject.other	bacteriophages
dc.subject.other	phage therapy
dc.subject.other	antibiotic resistance
dc.subject.other	Pseudomonas aeruginosa
dc.subject.other	Escherichia coli
dc.subject.other	Staphylococcus aureus
dc.subject.other	Brussels
dc.subject.other	Belgium
dc.subject.other	phage biocontrol
dc.subject.other	patent landscape
dc.subject.other	crop production
dc.subject.other	bacteriophage
dc.subject.other	phage therapy
dc.subject.other	multidrug-resistant bacteria
dc.subject.other	antimicrobial resistance
dc.subject.other	bacteriophage therapy
dc.subject.other	compassionate use
dc.subject.other	antibiotic resistance
dc.subject.other	phage therapy
dc.subject.other	PTMP
dc.subject.other	ATMP
dc.subject.other	regulatory framework
dc.subject.other	pharmaceutical paradigm shift
dc.subject.other	clinical trial
dc.subject.other	magistral formula
dc.subject.other	personalized medicine
dc.subject.other	phage therapy
dc.subject.other	E. faecalis
dc.subject.other	OrthoMCL
dc.subject.other	antimicrobial resistance
dc.subject.other	capsule
dc.subject.other	Galleria mellonella
dc.subject.other	Klebsiella pneumoniae
dc.subject.other	phage therapy
dc.subject.other	n/a
dc.subject.other	antimicrobial resistance
dc.subject.other	bacteriophage
dc.subject.other	personalised medicines
dc.subject.other	phage therapy
dc.subject.other	pharmaceutical legislation
dc.subject.other	regulatory framework
dc.title	Progress in Understanding Cystic Fibrosis
dc.type	電子教科書
dc.classification	自然科學類
Theme:	教科書-自然科學類

Files in This Item:

There are no files associated with this item.

Show simple item record

Taiwan MOOC OERs

Open Educational Resources (OER) are free and openly licensed educational materials that can be used for teaching, learning, research, and other purposes.